Thrombolytic Therapy for Stroke
暂无分享,去创建一个
[1] R. Macko,et al. Chronic reversible cerebral ischemia: evaluation of a new baboon model. , 1980, Neurosurgery.
[2] U. Degirolami,et al. Tissue plasminogen activator reduces neurological damage after cerebral embolism. , 1985, Science.
[3] W. Hacke,et al. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. , 1990, Stroke.
[4] K. Okada,et al. Cerebral Plasminogen Activator Activity in Spontaneously Hypertensive Stroke‐Prone Rats , 1992, Stroke.
[5] M. A. Dent,et al. Urokinase‐type Plasminogen Activator Expression by Neurons and Oligodendrocytes During Process Outgrowth in Developing Rat Brain , 1993, The European journal of neuroscience.
[6] G. Boysen,et al. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model. , 1993, Scandinavian journal of clinical and laboratory investigation.
[7] D. Belin,et al. Extracellular proteolysis in the adult murine brain. , 1993, The Journal of clinical investigation.
[8] G. Hamann,et al. Leukocyte involvement in vasomotor reactivity of the cerebral vasculature. , 1994, Stroke.
[9] R. Rothlein,et al. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy , 1995, Neurology.
[10] A. Beaudet,et al. Absence of trauma-induced leukocyte rolling in mice deficient in both P- selectin and intercellular adhesion molecule 1 , 1996, The Journal of experimental medicine.